Laboratory activities involving transmissible spongiform encephalopathy causing agents

References

• Bradley R, Collee JG, Liberski PP. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 1. Folia Neuropathol 2006; 44:93 - 101; PMID: 16823691
   PubMedGoogle Scholar
• EFSA panel on biological hazards and ECDC. Joint scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans. EFSA Journal 2011; 9:1945
   Google Scholar
• Collee JG, Bradley R, Liberski PP. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 2. Folia Neuropathol 2006; 44:102 - 10; PMID: 16823692
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278:245 - 51; http://dx.doi.org/10.1126/science.278.5336.245; PMID: 9323196
   PubMed Web of Science ®Google Scholar
• European Commission. Regulation n°999/2001 of the European Parliament and the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. Official Journal of the European Communities 2001;L147.
   Google Scholar
• Smith PG. The epidemics of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: current status and future prospects. Bull World Health Organ 2003; 81:123 - 30; PMID: 12751420
   PubMed Web of Science ®Google Scholar
• European Commission, Directorate-General for Health & consumers. The TSE Roadmap 2. 2010 Jul 16. Report: COM 2010;384.
   Google Scholar
• EFSA. Scientific and technical assistance on the minimum sample size to test should an annual BSE statistical testing regime be authorized in healthy slaughtered cattle. EFSA Journal 2012; 10:2913
   Google Scholar
• European Commission. DIRECTIVE 2000/54/EC of 18 September2000 on the protection of workers from risks related to exposure to biological agents at work. Official Journal of the European Communities 2000;L262.
   Google Scholar
• European Commission. Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms. Official Journal of the European Union 2009; L125:75
   Google Scholar
• Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid?. Nature 1967; 214:764 - 6; http://dx.doi.org/10.1038/214764a0; PMID: 4963878
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 4; http://dx.doi.org/10.1038/2151043a0; PMID: 4964084
   PubMed Web of Science ®Google Scholar
• McKinley MP, Masiarz FR, Prusiner SB. Reversible chemical modification of the scrapie agent. Science 1981; 214:1259 - 61; http://dx.doi.org/10.1126/science.6795721; PMID: 6795721
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 6; http://dx.doi.org/10.1126/science.1138718; PMID: 17991853
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MAM, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728; http://dx.doi.org/10.1152/physrev.00007.2007; PMID: 18391177
   PubMed Web of Science ®Google Scholar
• Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823 - 33; http://dx.doi.org/10.1038/nrm3007; PMID: 21081963
   PubMed Web of Science ®Google Scholar
• Hamir AN, Kehrli ME Jr., Kunkle RA, Greenlee JJ, Nicholson EM, Richt JA, Miller JM, Cutlip RC. Experimental interspecies transmission studies of the transmissible spongiform encephalopathies to cattle: comparison to bovine spongiform encephalopathy in cattle. J Vet Diagn Invest 2011; 23:407 - 20; http://dx.doi.org/10.1177/1040638711403404; PMID: 21908269
   PubMed Web of Science ®Google Scholar
• Radford H, Moreno J, Peretti D, Verity N, Guerra Martin MSJ, Mallucci G, et al. The role of PrP in synaptic function and repair - Implications for treatment of prion and Alzheimer diseases. Prion 2012 Conference 2012;6:2-22.
   Google Scholar
• Tatzelt J. The cellular prion protein mediates neurotoxic signaling of scrapie prions and Amyloid-beta. Prion 2012 Conference 2012;6:2-22.
   Google Scholar
• Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, et al. Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A 2010; 107:2295 - 300; http://dx.doi.org/10.1073/pnas.0911829107; PMID: 20133875
   PubMed Web of Science ®Google Scholar
• Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature 2010; 466:E3 - 4, discussion E4-5; http://dx.doi.org/10.1038/nature09217; PMID: 20703260
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540 - 2; http://dx.doi.org/10.1038/nature09768; PMID: 21350487
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer’s and Parkinson’s diseases. Nat Cell Biol 2004; 6:1054 - 61; http://dx.doi.org/10.1038/ncb1104-1054; PMID: 15516999
   PubMed Web of Science ®Google Scholar
• Fryer HR, McLean AR. There is no safe dose of prions. PLoS One 2011; 6:e23664; http://dx.doi.org/10.1371/journal.pone.0023664; PMID: 21858197
   PubMedGoogle Scholar
• Baier M, Norley S, Schultz J, Burwinkel M, Schwarz A, Riemer C. Prion diseases: infectious and lethal doses following oral challenge. J Gen Virol 2003; 84:1927 - 9; http://dx.doi.org/10.1099/vir.0.19037-0; PMID: 12810889
   PubMed Web of Science ®Google Scholar
• Jacquemot C, Cuche C, Dormont D, Lazarini F. High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol 2005; 79:8904 - 8; http://dx.doi.org/10.1128/JVI.79.14.8904-8908.2005; PMID: 15994784
   PubMed Web of Science ®Google Scholar
• Diringer H, Roehmel J, Beekes M. Effect of repeated oral infection of hamsters with scrapie. J Gen Virol 1998; 79:609 - 12; PMID: 9519841
   PubMed Web of Science ®Google Scholar
• Sim VL, Caughey B. Recent advances in prion chemotherapeutics. Infect Disord Drug Targets 2009; 9:81 - 91; http://dx.doi.org/10.2174/1871526510909010081; PMID: 19200018
   PubMedGoogle Scholar
• Ramachandran TS. Prion-related diseases. [Cited 2012 May 2]; Available from:.
   Google Scholar
• Buchholz CJ, Bach P, Nikles D, Kalinke U. Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies. Expert Opin Biol Ther 2006; 6:293 - 300; http://dx.doi.org/10.1517/14712598.6.3.293; PMID: 16503737
   PubMed Web of Science ®Google Scholar
• Kalinke U, Bach P, Koning M, Buchholz CJ. Vaccination against prion diseases. [Cited 2009 July 27]; Available from:
   Google Scholar
• Relaño-Ginés A, Lehmann S, Bencsik A, Herva ME, Torres JM, Crozet CA. Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. J Infect Dis 2011; 204:1038 - 45; http://dx.doi.org/10.1093/infdis/jir484; PMID: 21881119
   PubMed Web of Science ®Google Scholar
• Morales R, Abid K, Soto C. The prion strain phenomenon: Molecular basis and unprecedented features. Biochimica et Biophysica Acta (BBA) -. Molecular Basis of Disease 2007; 1772:681 - 91; http://dx.doi.org/10.1016/j.bbadis.2006.12.006
   PubMed Web of Science ®Google Scholar
• Owen F, Poulter MCJ, Collinge J, Crow TJ. Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet 1990; 46:1215 - 6; PMID: 2378641
   PubMed Web of Science ®Google Scholar
• Agrimi U. PrnP and susceptibility to prion diseases - from resistance to spontaneous disease. Prion 2012; 6:2 - 22
   Google Scholar
• Edgeworth JA, Sicilia A, Linehan J, Brandner S, Jackson GS, Collinge J. A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay. J Gen Virol 2011; 92:718 - 26; http://dx.doi.org/10.1099/vir.0.027201-0; PMID: 21084494
   PubMed Web of Science ®Google Scholar
• Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012; 38:296 - 310; http://dx.doi.org/10.1111/j.1365-2990.2012.01265.x; PMID: 22394291
   PubMed Web of Science ®Google Scholar
• Bourvis N, Boelle PY, Cesbron JY, Valleron AJ. Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivation. PLoS One 2007; 2:e1330; http://dx.doi.org/10.1371/journal.pone.0001330; PMID: 18159228
   PubMedGoogle Scholar
• Stitz L, Aguzzi A. Aerosols: an underestimated vehicle for transmission of prion diseases?. Prion 2011; 5:138 - 41; http://dx.doi.org/10.4161/pri.5.3.16851; PMID: 21778819
   PubMed Web of Science ®Google Scholar
• Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C, Mertz K, Zirdum E, Petsch B, Fuchs TJ, et al. Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog 2011; 7:e1001257; http://dx.doi.org/10.1371/journal.ppat.1001257; PMID: 21249178
   PubMed Web of Science ®Google Scholar
• Denkers ND, Seelig DM, Telling GC, Hoover EA. Aerosol and nasal transmission of chronic wasting disease in cervidized mice. J Gen Virol 2010; 91:1651 - 8; http://dx.doi.org/10.1099/vir.0.017335-0; PMID: 20164261
   PubMed Web of Science ®Google Scholar
• Nichols TA, Pulford B, Wyckoff AC, Meyerett C, Michel B, Gertig K, Hoover EA, Jewell JE, Telling GC, Zabel MD. Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion 2009; 3:171 - 83; http://dx.doi.org/10.4161/pri.3.3.9819; PMID: 19823039
   PubMed Web of Science ®Google Scholar
• Collinge J. Cell biology. The risk of prion zoonoses. Science 2012; 335:411 - 3; http://dx.doi.org/10.1126/science.1218167; PMID: 22282797
   PubMed Web of Science ®Google Scholar
• Bett C, Fernández-Borges N, Kurt TD, Lucero M, Nilsson KP, Castilla J, Sigurdson CJ. Structure of the β2-α2 loop and interspecies prion transmission. FASEB J 2012; 26:2868 - 76; http://dx.doi.org/10.1096/fj.11-200923; PMID: 22490928
   PubMed Web of Science ®Google Scholar
• Béringue V. Prion diversity and evolution - what animal strain typing tells us. Prion 2012; 6:2 - 22
   Google Scholar
• Béringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H. Facilitated cross-species transmission of prions in extraneural tissue. Science 2012; 335:472 - 5; http://dx.doi.org/10.1126/science.1215659; PMID: 22282814
   PubMed Web of Science ®Google Scholar
• Brown P, Gajdusek DC. Survival of scrapie virus after 3 years’ interment. Lancet 1991; 337:269 - 70; http://dx.doi.org/10.1016/0140-6736(91)90873-N; PMID: 1671114
   PubMed Web of Science ®Google Scholar
• Smith CB, Booth CJ, Pedersen JA. Fate of prions in soil: a review. J Environ Qual 2011; 40:449 - 61; http://dx.doi.org/10.2134/jeq2010.0412; PMID: 21520752
   PubMed Web of Science ®Google Scholar
• Wyckoff C, Vercauteren KZM. Estimating prion binding capacity of soil. Prion 2012; 6:137 - 43
   Web of Science ®Google Scholar
• Maluquer de Motes C, Cano MJ, Torres JM, Pumarola M, Girones R. Detection and survival of prion agents in aquatic environments. Water Res 2008; 42:2465 - 72; http://dx.doi.org/10.1016/j.watres.2008.01.031; PMID: 18321558
   PubMed Web of Science ®Google Scholar
• Health Safety Executive ACDP. The approved list of biological agents. 2004. http://www.hse.gov.uk/pubns/misc208.pdf
   Google Scholar
• Service Biosécurité et Biotechnologie. List of viruses and unconventional agents presenting at the wild state a biological risk for immunocompetent humans and/or animals and corresponding maximum biological risk. 2009.
   Google Scholar
• Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009; 338:b1442; http://dx.doi.org/10.1136/bmj.b1442; PMID: 19460798
   PubMed Web of Science ®Google Scholar
• Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733 - 9; http://dx.doi.org/10.1002/path.1580; PMID: 15221931
   PubMed Web of Science ®Google Scholar
• World Organisation for Animal Health. BSE: Manual of diagnostic tests and vaccines for terrestrial animals. 2010.
   Google Scholar
• de Marco MF, Linehan J, Gill ON, Clewley JP, Brandner S. Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 2010; 222:380 - 7; http://dx.doi.org/10.1002/path.2767; PMID: 20922767
   PubMed Web of Science ®Google Scholar
• Arellano-Anaya ZE, Savistchenko J, Mathey J, Huor A, Lacroux C, Andréoletti O, Vilette D. A simple, versatile and sensitive cell-based assay for prions from various species. PLoS One 2011; 6:e20563; http://dx.doi.org/10.1371/journal.pone.0020563; PMID: 21655184
   PubMedGoogle Scholar
• Edgeworth JA, Jackson GS, Clarke AR, Weissmann C, Collinge J. Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proceedings of the National Academy of Sciences 2009;Early edition:1-5.
   Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 3; http://dx.doi.org/10.1038/35081095; PMID: 11459061
   PubMed Web of Science ®Google Scholar
• Caughey B, Orrù CD, Wilham JM, Vascellari S, Hyghson AG, Raymond LD, et al. Prion-seeded conversion of recombinant PrP: implications for prion biology and diagnostics. Prion 2012; 6:2 - 22
   Google Scholar
• Centers for Disease Control and Prevention (US), National Institutes of Health. Prion diseases. In: Chosewood LC, Wilson DE, editors. Biosafety in Microbiological and Biomedical Laboratories. 5th ed. CDC; 2009. 282-289.
   Google Scholar
• CEN. Laboratory biorisk management. Report: CWA 2011; 15793:2011
   Google Scholar
• Murphy RGL, Scanga JA, Powers BE, Pilon JL, Vercauteren KC, Nash PB, Smith GC, Belk KE. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material. J Anim Sci 2009; 87:1787 - 93; http://dx.doi.org/10.2527/jas.2008-1492; PMID: 19098230
   PubMed Web of Science ®Google Scholar
• Taylor DM, Fernie K, McConnell I. Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide. Vet Microbiol 1997; 58:87 - 91; http://dx.doi.org/10.1016/S0378-1135(97)00103-X; PMID: 9453120
   PubMed Web of Science ®Google Scholar
• Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 2000; 159:10 - 7; http://dx.doi.org/10.1053/tvjl.1999.0406; PMID: 10640408
   PubMed Web of Science ®Google Scholar
• Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, Lasmézas CI, Deslys JP. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521 - 6; http://dx.doi.org/10.1016/S0140-6736(04)16810-4; PMID: 15302195
   PubMed Web of Science ®Google Scholar
• Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM. Oral transmissibility of prion disease is enhanced by binding to soil particles. PLoS Pathog 2007; 3:e93; http://dx.doi.org/10.1371/journal.ppat.0030093; PMID: 17616973
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO infection control guidelines for transmissible spongiform encephalopathies. 2000. Report: WHO/CDS/CSR/APH/2000.3.
   Google Scholar
• Rutala WA, Weber DJ, Society for Healthcare Epidemiology of America. Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol 2010; 31:107 - 17; http://dx.doi.org/10.1086/650197; PMID: 20055640
   PubMed Web of Science ®Google Scholar
• Müller H, Stitz L, Wille H, Prusiner SB, Riesner D. Influence of water, fat, and glycerol on the mechanism of thermal prion inactivation. J Biol Chem 2007; 282:35855 - 67; http://dx.doi.org/10.1074/jbc.M706883200; PMID: 17878157
   PubMed Web of Science ®Google Scholar
• Rogez-Kreuz C, Yousfi R, Soufflet C, Quadrio I, Yan ZX, Huyot V, Aubenque C, Destrez P, Roth K, Roberts C, et al. Inactivation of animal and human prions by hydrogen peroxide gas plasma sterilization. Infect Control Hosp Epidemiol 2009; 30:769 - 77; http://dx.doi.org/10.1086/598342; PMID: 19563265
   PubMed Web of Science ®Google Scholar
• Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487 - 93; http://dx.doi.org/10.1016/S0140-6736(10)62308-2; PMID: 21295339
   PubMed Web of Science ®Google Scholar
• Bauman PA, Lawrence LA, Biesert L, Dichtelmüller H, Fabbrizzi F, Gajardo R, Gröner A, Jorquera JI, Kempf C, Kreil TR, et al. Critical factors influencing prion inactivation by sodium hydroxide. Vox Sang 2006; 91:34 - 40; http://dx.doi.org/10.1111/j.1423-0410.2006.00790.x; PMID: 16756599
   PubMed Web of Science ®Google Scholar
• Elmoualij B, Thellin O, Gofflot S, Heinen E, Levif P, Séguin J, et al. Decontamination of prions by the flowing afterglow of a reduced-pressure N2−O2 cold-plasma. Plasma Process Polym 2012; 9:612 - 8; http://dx.doi.org/10.1002/ppap.201100194
   Web of Science ®Google Scholar
• Lehmann S, Pastore M, Rogez-Kreuz C, Richard M, Belondrade M, Rauwel G, Durand F, Yousfi R, Criquelion J, Clayette P, et al. New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. J Hosp Infect 2009; 72:342 - 50; http://dx.doi.org/10.1016/j.jhin.2009.03.024; PMID: 19541387
   PubMed Web of Science ®Google Scholar
• Fichet G, Antloga K, Comoy E, Deslys JP, McDonnell G. Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. J Hosp Infect 2007; 67:278 - 86; http://dx.doi.org/10.1016/j.jhin.2007.08.020; PMID: 17942185
   PubMed Web of Science ®Google Scholar
• Leunda A, Pauwels K, Herman P, Verheust C, Zorzi W, Thellin O, et al. Risk assessment of laboratories involving the manipulation of unconventional agents causing TSE. Brussels: Scientific Institute of Public Health; 2009. Report: D/2009/2505/49.
   Google Scholar
• Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 1999; 5:240 - 3; PMID: 10448646
   PubMed Web of Science ®Google Scholar
• Maddison B, Baker C, Gough K, Hawkins S, Simmons H. Evaluation of pen decontamination regimes for the effective removal of environmental scrapie. Prion 2012; 6:137 - 43
   Web of Science ®Google Scholar
• Leunda A, Roels S, Van Vaerenbergh B. Dismantlement of laboratories performing rapid detection of Transmissible Spongiform Encephalopathy. 2011. Report: ISP/41/CU/11-1034. http://www.biosafety.be/CU/PDF/Dismantlement_Lab_TSE.pdf
   Google Scholar